Security key
79400X305
SALARIUS PHARMACEUTICALS INC - COM NEW (SLRX)
CUSIP: 79400X305
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 262,705
- Total 13F value
- $169,771
- Share change
- -81,601
- SEC-reported price per share
- $0.65
- Number of holders
- 16
- Value change
- -$53,470
- Number of buys
- 6
- Number of sells
- 6
Report period
Q4 2023
Institutions
16
Top holders
10
SLRX full security history
Ownership snapshot
Full 13F holder table
Decoy Therapeutics Inc. SEC filings
Decoy Therapeutics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of SLRX - SALARIUS PHARMACEUTICALS INC - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/14
Latest evidence
30 Sep 2023
13F
Highest disclosed value: $148,028
14 rows are not safely comparable across share classes.
Showing 1-6 of 14 holder rows.
Quick read
ARMISTICE CAPITAL, LLC has the largest disclosed position value at $148K.
0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Disclosed position value
Top 5
ARMISTICE CAPITAL, LLC
$148K
HORIZON KINETICS ASSET MANAGEMENT...
$21.3K
GEODE CAPITAL MANAGEMENT, LLC
$16.4K
RENAISSANCE TECHNOLOGIES LLC
$16K
VANGUARD GROUP INC
$9.4K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 14 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$148,028
225,000 shares
|
— | 30 Sep 2023 |
| HORIZON KINETICS ASSET MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$21,316
32,400 shares
|
— | 30 Sep 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$16,395
24,771 shares
|
— | 30 Sep 2023 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$16,000
24,142 shares
|
— | 30 Sep 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$9,384
14,263 shares
|
— | 30 Sep 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
—
denominator unverified
|
$9,066
13,697 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
16
Shares
262,705
Rows available
16
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
14
Q4 2023 holders
16
Holder diff
2
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|